强生公司宣布将投入超过10亿美元,于宾夕法尼亚州蒙哥马利县新建一座尖端细胞疗法生产设施。这一重大投资旨在加速创新疗法的研发与商业化进程,进一步巩固强生在生物制药领域的领先地位。
强生公司宣布将投入超过10亿美元,于宾夕法尼亚州蒙哥马利县新建一座尖端细胞疗法生产设施。这一重大投资旨在加速创新疗法的研发与商业化进程,进一步巩固强生在生物制药领域的领先地位。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.